A Prospective Clinical Trial Comparing Serum Mast Cell Tryptase (SMCT) Levels to Arthrofibrosis Rates Among Primary Total Knee Arthroplasty (TKA) Patients

CompletedOBSERVATIONAL
Enrollment

219

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

November 15, 2023

Study Completion Date

November 15, 2023

Conditions
Knee OsteoarthritisArthropathy of KneeArthrofibrosis
Interventions
DIAGNOSTIC_TEST

Tryptase, Serum test

Blood draw lab test which measures concentration of Tryptase in the sample. Tryptase is the one of the primary secretions of active mast cells and is used as a measure of inflammatory activity. Normal Reference Value: \<11.5 ng/mL

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER